CIK 0001512762
- Accelerated filer
- Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273615821
- Phone
- +1 650-649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- 4 Open-market sale Chief Scientific Officer sold 4,250 shares at $16.89 ($71,775)
- 4 Open-market sale Chief Scientific Officer sold 4,250 shares at $18.67 ($79,360)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market sale Director sold 6,372 shares at $33.50 ($213,475)
- 4 Open-market sale Chief Technical Officer sold 12,000 shares at $20.00 ($240,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Technical Officer sold 21,493 shares at an average $26.89 ($578,038)
- 4/A Derivatives Options or other derivatives
- 4 Open-market sale Chief Scientific Officer sold 4,250 shares at an average $19.20 ($81,592)
Page 16 of 20 · 399 filings